🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study was an international, multicenter, open-label, long term extensi...
Status
Completed
Location
Harmonex Neuroscience Research
Start Date
2019-10-04
Trial ID
NCT04114539
Treatments Being Tested
Standard food-effect study to identify the effect of food on ecopipam pharm...
Status
Completed
Location
ICON Early Phase Services
Start Date
2024-11-05
Trial ID
NCT06669091
Treatments Being Tested
This Phase 3 multicenter study evaluates the maintenance of efficacy, safet...
Status
Completed
Location
Harmonex Neuroscience Research
Start Date
2023-01-31
Trial ID
NCT05615220
Treatments Being Tested
This is an exploratory, double blinded cross-over study of the D1 antagonis...
Status
Completed
Location
Houston Methodist Hospital
Start Date
2017-09-18
Trial ID
NCT03218969
This study is designed to test the hypothesis that ecopipam is able to redu...
Status
Completed
Location
University of California, Los Angeles
Start Date
2010-10
Trial ID
NCT01215357
Treatments Being Tested
This study evaluates the effect of ecopipam tablets in children and adolesc...
Status
Completed
Location
Harmonex Neuroscience Research
Start Date
2019-06-28
Trial ID
NCT04007991
This is a single center, open-label, fixed sequence Phase 1, drug-drug inte...
Status
Completed
Location
ICON Early Phase Services
Start Date
2022-04-26
Trial ID
NCT05334108
Phase 1, single-center (United Kingdom), open-label, nonrandomized, single-...
Status
Completed
Location
Covance Clinical Research Unit Ltd.
Start Date
2021-05-12
Trial ID
NCT04881955
Treatments Being Tested
This is a single center, 2-Part, Phase 1, open-label, fixed-sequence, drug-...
Status
Completed
Location
Syneos Health Clinic Inc.
Start Date
2024-01-18
Trial ID
NCT06194864
Treatments Being Tested
The primary objective of this study is to evaluate the long-term safety and...
Status
Active Not Recruiting
Location
Harmonex, Inc.
Start Date
2023-08-16
Trial ID
NCT06021522
Treatments Being Tested